probenecid has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carozzo, A | 1 |
| Yaneff, A | 1 |
| Gómez, N | 1 |
| Di Siervi, N | 1 |
| Sahores, A | 1 |
| Diez, F | 1 |
| Attorresi, AI | 1 |
| Rodríguez-González, Á | 1 |
| Monczor, F | 1 |
| Fernández, N | 1 |
| Abba, M | 1 |
| Shayo, C | 1 |
| Davio, C | 1 |
1 other study available for probenecid and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux.
Topics: Benzothiazoles; Carcinoma, Pancreatic Ductal; Cell Differentiation; Cell Line, Tumor; Cell Prolifera | 2019 |